Nanexa
1.27
SEK
+4.1 %
NANEXA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
+4.1%
-16.72%
-18.06%
+44.32%
+3.25%
+73.5%
-68.49%
-87.97%
-84.48%
nanexa.com
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Revenue
29.33M
EBIT %
-261.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NANEXA
Daily low / high price
1.075 / 1.415
SEK
Market cap
172.33M SEK
Turnover
981.48K SEK
Volume
778K
Latest videos
Financial calendar
Annual report
2025-02-19
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Novo Nordisk A/S | 19.9 % | 19.9 % |
| Nordnet Pensionsförsäkring | 5.6 % | 5.6 % |
| Applied Ventures, LLC. | 5.2 % | 5.2 % |
| Avanza Pension | 4.8 % | 4.8 % |
| M2 Capital Management AB | 3.1 % | 3.1 % |
| Jan Christer Petersen | 2.6 % | 2.6 % |
| Mikael Jacobsson | 2.4 % | 2.4 % |
| Jonas Pålsson | 2.3 % | 2.3 % |
| Gunvald Berger | 1.9 % | 1.9 % |
| Ivar Nordqvist | 1.8 % | 1.8 % |
ShowingAll content types
Nanexa publicerar delårsrapport för januari-september 2024
Inbjudan till presentation av Nanexas Q3-rapport 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools